Acute Kidney Injury Clinical Trial
— EurAKIDOfficial title:
European Registry of Dialysis Treatment of Pediatric Acute Kidney Injury (AKI)
| NCT number | NCT02960867 |
| Other study ID # | 1041_OPBG_2016 |
| Secondary ID | |
| Status | Completed |
| Phase | |
| First received | |
| Last updated | |
| Start date | April 2016 |
| Est. completion date | April 2019 |
| Verified date | May 2019 |
| Source | Bambino Gesù Hospital and Research Institute |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational [Patient Registry] |
Acute kidney injury (AKI) is a frequent clinical condition in hospitalized, in particular, in
critically ill children. Moreover, AKI is an independent predictor of mortality. An incidence
of AKI in pediatric intensive care units (PICU) between 10 and 62% has been reported in
recent clinical trials adopting pRIFLE or AKIN criteria, with the highest risk present in
cardiac surgery patients. Despite significant developments in the management of AKI, the
overall mortality rate of patients with AKI has not improved significantly. Currently, there
is no consensus concerning the optimum dialysis modalities to adopt in pediatric AKI. No
studies have prospectively compared the efficacy of different types of RRT for pediatric AKI.
While PD remains the most commonly used modality in children worldwide, over the last decade
CRRT has become the preferred treatment modality for critically ill children with AKI in
North America.
The investigators have recently conducted a survey among 34 European Pediatric Nephrology
Centers in the ESCAPE Network to obtain current information on dialysis management practices
in children. Approximately 900 children with AKI requiring dialysis are managed at these 34
centers per year. This number supports the creation of a prospective European AKI registry.
| Status | Completed |
| Enrollment | 1892 |
| Est. completion date | April 2019 |
| Est. primary completion date | March 2019 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | N/A to 18 Years |
| Eligibility |
Inclusion Criteria: - Children with AKI at Hospital admission or who developed AKI during hospitalization treated with dialysis (PD, HD, CRRT) - Age: 0-18 yrs Exclusion Criteria: - Children with known preexisting CKD (i.e.: AKI on CKD) |
| Country | Name | City | State |
|---|---|---|---|
| Italy | Department of Nephrology-Urology "Bambino Gesù" Children's Research Hospital | Rome |
| Lead Sponsor | Collaborator |
|---|---|
| Mariella Enoc | Baxter Healthcare Corporation |
Italy,
Akcan-Arikan A, Zappitelli M, Loftis LL, Washburn KK, Jefferson LS, Goldstein SL. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int. 2007 May;71(10):1028-35. Epub 2007 Mar 28. — View Citation
Alabbas A, Campbell A, Skippen P, Human D, Matsell D, Mammen C. Epidemiology of cardiac surgery-associated acute kidney injury in neonates: a retrospective study. Pediatr Nephrol. 2013 Jul;28(7):1127-34. doi: 10.1007/s00467-013-2454-3. Epub 2013 Mar 22. — View Citation
Alkandari O, Eddington KA, Hyder A, Gauvin F, Ducruet T, Gottesman R, Phan V, Zappitelli M. Acute kidney injury is an independent risk factor for pediatric intensive care unit mortality, longer length of stay and prolonged mechanical ventilation in critic — View Citation
Bailey D, Phan V, Litalien C, Ducruet T, Mérouani A, Lacroix J, Gauvin F. Risk factors of acute renal failure in critically ill children: A prospective descriptive epidemiological study. Pediatr Crit Care Med. 2007 Jan;8(1):29-35. — View Citation
Barrantes F, Tian J, Vazquez R, Amoateng-Adjepong Y, Manthous CA. Acute kidney injury criteria predict outcomes of critically ill patients. Crit Care Med. 2008 May;36(5):1397-403. doi: 10.1097/CCM.0b013e318168fbe0. — View Citation
Basu RK, Zappitelli M, Brunner L, Wang Y, Wong HR, Chawla LS, Wheeler DS, Goldstein SL. Derivation and validation of the renal angina index to improve the prediction of acute kidney injury in critically ill children. Kidney Int. 2014 Mar;85(3):659-67. doi — View Citation
Duzova A, Bakkaloglu A, Kalyoncu M, Poyrazoglu H, Delibas A, Ozkaya O, Peru H, Alpay H, Soylemezoglu O, Gur-Guven A, Bak M, Bircan Z, Cengiz N, Akil I, Ozcakar B, Uncu N, Karabay-Bayazit A, Sonmez F; Turkish Society for Pediatric Nephrology Acute Kidney I — View Citation
Medina Villanueva A, López-Herce Cid J, López Fernández Y, Antón Gamero M, Concha Torre A, Rey Galán C, Santos Rodríguez F. [Acute renal failure in critically-ill children. A preliminary study]. An Pediatr (Barc). 2004 Dec;61(6):509-14. Spanish. — View Citation
Schneider J, Khemani R, Grushkin C, Bart R. Serum creatinine as stratified in the RIFLE score for acute kidney injury is associated with mortality and length of stay for children in the pediatric intensive care unit. Crit Care Med. 2010 Mar;38(3):933-9. d — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | incidence of AKI requiring dialysis in PICU and non-PICU children | urine output and serum creatinine | 3 years | |
| Secondary | Mortality rates | mortality | 3 years | |
| Secondary | difference in mortality related to dialysis modality | CRRT modality (CVVH, CVVHD, CVVHDF) | 3 years | |
| Secondary | difference in the primary outcome related to duration of mechanical ventilation | duration of mechanical ventilation | 3 years | |
| Secondary | difference in the primary outcome related to severity score | severity score | 3 years | |
| Secondary | difference in the primary outcome related to SpO2 | SpO2 | 3 years | |
| Secondary | difference in the primary outcome related to FiO2 | FiO2 | 3 years | |
| Secondary | difference in the primary outcome related to Mean Airway Pressure | Mean Airway Pressure | 3 years | |
| Secondary | difference in the primary outcome related to paO2 | paO2 | 3 years |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05538351 -
A Study to Support the Development of the Enhanced Fluid Assessment Tool for Patients With Acute Kidney Injury
|
||
| Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
| Completed |
NCT03938038 -
Guidance of Ultrasound in Intensive Care to Direct Euvolemia
|
N/A | |
| Recruiting |
NCT05805709 -
A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
|
N/A | |
| Recruiting |
NCT05318196 -
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
|
||
| Recruiting |
NCT05897840 -
Continuous Central Venous Oxygen Saturation Measurement as a Tool to Predict Hemodynamic Instability Related to Renal Replacement Therapy in Critically Ill Patients
|
N/A | |
| Recruiting |
NCT04986137 -
Fractional Excretion of Urea for the Differential Diagnosis of Acute Kidney Injury in Cirrhosis
|
||
| Terminated |
NCT04293744 -
Acute Kidney Injury After Cardiac Surgery
|
N/A | |
| Completed |
NCT04095143 -
Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury
|
||
| Not yet recruiting |
NCT06026592 -
Detection of Plasma DNA of Renal Origin in Kidney Transplant Patients
|
||
| Not yet recruiting |
NCT06064305 -
Transcriptional and Proteomic Analysis of Acute Kidney Injury
|
||
| Terminated |
NCT03438877 -
Intensive Versus Regular Dosage For PD In AKI.
|
N/A | |
| Terminated |
NCT03305549 -
Recovery After Dialysis-Requiring Acute Kidney Injury
|
N/A | |
| Completed |
NCT05990660 -
Renal Assist Device (RAD) for Patients With Renal Insufficiency Undergoing Cardiac Surgery
|
N/A | |
| Completed |
NCT04062994 -
A Clinical Decision Support Trial to Reduce Intraoperative Hypotension
|
||
| Terminated |
NCT02860130 -
Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)
|
Phase 3 | |
| Completed |
NCT06000098 -
Consol Time and Acute Kidney Injury in Robotic-assisted Prostatectomy
|
||
| Not yet recruiting |
NCT05548725 -
Relation Between Acute Kidney Injury and Mineral Bone Disease
|
||
| Completed |
NCT02665377 -
Prevention of Akute Kidney Injury, Hearttransplant, ANP
|
Phase 3 | |
| Terminated |
NCT03539861 -
Immunomodulatory Biomimetic Device to Treat Myocardial Stunning in End-stage Renal Disease Patients
|
N/A |